Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Restructuring Costs (2016 - 2025)

Surgery Partners (SGRY) has disclosed Restructuring Costs for 12 consecutive years, with $18.5 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs fell 45.59% to $18.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $73.9 million through Dec 2025, down 26.17% year-over-year, with the annual reading at $73.9 million for FY2025, 26.17% down from the prior year.
  • Restructuring Costs hit $18.5 million in Q4 2025 for Surgery Partners, up from $12.6 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $34.0 million in Q4 2024 to a low of $5.3 million in Q1 2021.
  • Historically, Restructuring Costs has averaged $16.2 million across 5 years, with a median of $14.0 million in 2021.
  • Biggest five-year swings in Restructuring Costs: soared 129.69% in 2024 and later plummeted 57.14% in 2025.
  • Year by year, Restructuring Costs stood at $15.1 million in 2021, then soared by 30.46% to $19.7 million in 2022, then rose by 23.86% to $24.4 million in 2023, then soared by 39.34% to $34.0 million in 2024, then tumbled by 45.59% to $18.5 million in 2025.
  • Business Quant data shows Restructuring Costs for SGRY at $18.5 million in Q4 2025, $12.6 million in Q3 2025, and $18.1 million in Q2 2025.